Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 7347
Country/Region: Cambodia
Year: 2008
Main Partner: U.S. Centers for Disease Control and Prevention
Main Partner Program: NA
Organizational Type: Own Agency
Funding Agency: HHS/CDC
Total Funding: $250,000

Funding for Care: TB/HIV (HVTB): $250,000

The emphasis area of this activity is to improve the diagnosis of TB among HIV-infected persons through

enhancement of tuberculosis laboratory capacity.

In FY 08, the USG will work alongside the Cambodia national TB program (CENAT) to expand capacity for

culture and drug-susceptibility testing at the one national laboratory and one provincial laboratory. The

target population includes all HIV-infected persons in HIV care services, as any of these persons would be

able to get sputum culture if needed. Making liquid culture available would be a major focus of this

laboratory expansion. Other laboratory enhancements would include strengthening external quality

assurance and proficiency testing in those laboratories for microscopy and solid culture, training, and

development of human resources. This activity augments current GFATM activities, which support smear

microscopy and chest radiography, both of which are components of TB diagnosis in HIV-infected persons.

In addition to enhancing laboratory capacity, the USG will also develop a transportation network to deliver

specimens from HIV care facilities in Pursat, Battambang, and Banteay Meanchey to the provincial

laboratory, which is in Battambang, one of 3 provinces in which the USG supports TB/HIV activities.

Banteay Meanchey and Pursat, the other two provinces the USG supports are adjacent to Battambang.

This activity links to other TB/HIV activities by improving the diagnosis of TB among HIV-infected persons in

HIV care within these 3 provinces, which increases the number of HIV-infected persons diagnosed with TB

and excludes TB for a larger group of HIV-infected persons, thus allowing the initiation of isoniazid

preventive therapy in these provinces.

In FY 08, the USG will continue to engage partners, including the Tuberculosis Control Assistance Program

(TBCAP) and the Japan Anti-Tuberculosis Association (JATA) to assist with the development of this system.

In order to achieve the above results, the USG will conduct: site-assessments of existing TB laboratories in

Battambang and at CENAT, fund any renovations needed prior to implementing liquid culture, procure

supplies and equipment needed, provide training for solid and liquid-based culture techniques, identification,

and drug-susceptibility testing, develop systems for transport of specimens to the laboratories, strengthen

laboratory information management system for monitoring and evaluation of laboratory capacity

enhancements, provide technical assistance for all aspects of this work.